health-trends

Indian startup achieves breakthrough in early cancer detection

Cancer is one of the leading causes of death globally, accounting for nearly 10 million deaths in 2020. In India alone, there are over 2.25 million cancer patients, with 0.8 million people estimated to die from the disease every year. Mumbai-based Epigeneres Biotechnology and Singapore-based Tzar Labs, led by Himanshu Roy's father-in-law scientist Vinay Kumar Tripathi and his sons, Anish and Ashish, have come up with a novel blood test that can not only detect cancer at the pre-tumour stage, but also tell if a person is at the risk of getting cancer for the next year. Interestingly, author Amish Tripathi is Ashish's twin brother. Moneycontrol's Chandra R Srikanth spoke to Ashish Tripathi.

first published: May 26, 2021 12:17 pm